Loneliness as a Marker of Brain Amyloid Burden and Preclinical Alzheimer Disease
Author:
- 1 December 2016
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 73 (12) , 1237-1238
Abstract
Treatment development in Alzheimer disease (AD) has been systematically moving to earlier stages of disease to target prodromal and even preclinical stages of AKeywords
This publication has 1 reference indexed in Scilit: